TREATMENT HAS ALREADY CHANGED MILLIONS OF LIVES IN THIS BUILDING. ONE DOCTOR DISCOVERED A BREAKTHROUGH THAT IS CHANGING THE LIVES OF PEOPLE LIVING WITH MULTIPLE SCLEROSIS. THESE PATIENTS, WITH ...
Cabaletta Bio, Inc. ((CABA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem. The program, presented by ...
Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...
A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results